Chemed (CHE) Other Accumulated Expenses (2009 - 2026)

Chemed has reported Other Accumulated Expenses for 18 years, with the latest figure at $72.5 million in Q2 2026.

• Other Accumulated Expenses for Q2 2026 came in at $72.5 million, up 8.32% year-over-year; the trailing twelve-month figure through Jun 2026 was $72.5 million (up 8.32% YoY), and the FY2025 annual result was $62.1 million, up 9.44% from the prior year.
• Other Accumulated Expenses improved to $72.5 million in Q2 2026, from $65.1 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $84.7 million in Q2 2023 and troughed at $54.8 million in Q2 2022.
• A 5-year average of $63.5 million and a median of $61.6 million in 2023 frame the typical range for Other Accumulated Expenses.
• The widest annual swing landed in 2023, when Other Accumulated Expenses soared 54.5%; it then dropped 29.29% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $61.0 million in 2022, then slipped by 3.99% to $58.6 million in 2023, then retreated by 3.18% to $56.7 million in 2024, then rose by 9.44% to $62.1 million in 2025, then gained by 16.76% to $72.5 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $72.5 million in Q2 2026, $65.1 million in Q1 2026, and $62.1 million in Q4 2025.